Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07152470 · ClinicalTrials.gov registry record
An Open Label 100 Person Study Evaluating a Natural Supplement for Weight Loss and Fat Loss.
A clinical trial of Overweight and Obesity, sponsored by Prostasis, LLC, dba Tonum Health.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07152470: Active study of Overweight and Obesity, sponsored by Prostasis, LLC, dba Tonum Health.
NCT07152470 is a study of Overweight and Obesity that is active but no longer recruiting, run by Prostasis, LLC, dba Tonum Health. The registered enrollment target is 100 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07152470, a study of Overweight and Obesity, is active but no longer recruiting, sponsored by Prostasis, LLC, dba Tonum Health.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if motus, a natural supplement can support healthy weight loss and fat loss in a real world setting without caloric restrictions or exercise requirements. The main questions it aims to answer are: Can a daily dose of motus result in statistically significant weight loss over 3 month and 6 month time points. Participants will: Weigh-in at baseline and every week thereafter Take drug motus every day Complete a food tracker app for every meal and drink product consumed daily Complete an exercise tracker for any activities performed daily Complete weekly satisfaction surveys on various topics
Primary Outcome
Total weight loss as a percentage of total body weight
Conditions Studied
Interventions
- BEHAVIORAL Diet and Exercise Tracking
Study Locations (1)
Florida
- Tonum Health - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-26 |
| Est. Completion | 2025-12-26 |
What the registry record for NCT07152470 still lists
NCT07152470 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which Diet and Exercise Tracking is the first listed.
NCT07152470 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07152470 about?
NCT07152470 is a clinical study titled "An Open Label 100 Person Study Evaluating a Natural Supplement for Weight Loss and Fat Loss.". The goal of this clinical trial is to learn if motus, a natural supplement can support healthy weight loss and fat loss in a real world setting without caloric restrictions or exercise requirements. The main questions it aims to answer are: Can a daily dose of motus result in statistically signifi...
What is the current status of trial NCT07152470?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2025-01-26. Estimated completion is 2025-12-26.
What conditions does trial NCT07152470 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT07152470?
The interventions under investigation include: Diet and Exercise Tracking (BEHAVIORAL).
Who is sponsoring clinical trial NCT07152470?
This trial is sponsored by Prostasis, LLC, dba Tonum Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07152470 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07152470's enrollment target sits among peer trials
100 56th of 115 higher than 58 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Breathing & Blood Pressure
RECRUITING
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI